These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 1539331)

  • 1. Extreme hypercholeresis in a patient with a transplanted liver reduced by treatment with somatostatin.
    Friman S; Wingren U; Asztély M; Persson H; Karlberg I
    Transplant Proc; 1992 Feb; 24(1):394-5. PubMed ID: 1539331
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of somatostatin for complications occurring after liver transplantation.
    Van de Stadt J; Gelin M; Jacobs F; Bourgeois N; Lambert M; Adler M; Lambilliotte JP
    Transplant Proc; 1990 Oct; 22(5):2257-60. PubMed ID: 1699335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of ursodeoxycholic acid treatment for cholestasis in liver transplant recipients.
    Rafael E; Duraj F; Rudström H; Wilczek H; Ericzon B
    Transplant Proc; 1995 Dec; 27(6):3501-2. PubMed ID: 8540069
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of somatostatin in biliary fistulas of transplanted livers.
    Railo M; Salmela K; Isoniemi H; Kyllönen L; Höckerstedt K
    Transplant Proc; 1992 Feb; 24(1):391-3. PubMed ID: 1539330
    [No Abstract]   [Full Text] [Related]  

  • 5. Postoperative chylous ascites in a neonate treated successfully with octreotide: bile sludge and cholestasis.
    Andreou A; Papouli M; Papavasiliou V; Badouraki M
    Am J Perinatol; 2005 Nov; 22(8):401-4. PubMed ID: 16283598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bilirubin secretion as an early indicator of patient survival following orthotopic liver transplantation.
    Forster J; Yan ZY; Payne KM; Wood JG; Eisenach JB; Delcore R
    Transplant Proc; 1993 Apr; 25(2):1889-90. PubMed ID: 8470215
    [No Abstract]   [Full Text] [Related]  

  • 7. Randomized controlled trial comparing somatostatin with octreotide in the prevention of complications after pancreatectomy.
    Closset J; Journe S; Mboti F; El Nakadi I; Gelin M
    Hepatogastroenterology; 2008; 55(86-87):1818-23. PubMed ID: 19102400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum cholestasis markers as predictors of early outcome after liver transplantation.
    Ben-Ari Z; Weiss-Schmilovitz H; Sulkes J; Brown M; Bar-Nathan N; Shaharabani E; Yussim A; Shapira Z; Tur-Kaspa R; Mor E
    Clin Transplant; 2004 Apr; 18(2):130-6. PubMed ID: 15016125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonspecific cholestatic syndrome in liver transplantation: successful symptomatic treatment by plasma exchange.
    Bruzzone P; Alfani D; Berloco P; Iappelli M; Rossi M; Casciaro G; Caricato M; Caramiello MS; Fagiolo M; Russo GE
    Transplant Proc; 1993 Apr; 25(2):1753-4. PubMed ID: 8470153
    [No Abstract]   [Full Text] [Related]  

  • 10. Cholestatic action of somatostatin in the rat: effect on the different fractions of bile secretion.
    Ricci GL; Fevery J
    Gastroenterology; 1981 Sep; 81(3):552-62. PubMed ID: 6114014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Post-cholestatic hypercholeresis in a patient with malignant obstruction of the bile ducts].
    Weigand K
    Schweiz Med Wochenschr; 1993 Jul; 123(26):1351-3. PubMed ID: 8342004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Gastrointestinal fistulas. Treatment with a somatostatin analogue (SMS 201-995)].
    Gerardo Pérez D; Bernardo Acosta M
    G E N; 1994; 48(4):209-18. PubMed ID: 7557275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biliary secretion of bile acids and lipids in primary sclerosing cholangitis. Influence of cholestasis and effect of ursodeoxycholic acid treatment.
    Stiehl A; Rudolph G; Sauer P; Theilmann L
    J Hepatol; 1995 Sep; 23(3):283-9. PubMed ID: 8550992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reperfusion damage to the bile canaliculi in transplanted human liver.
    Cutrin JC; Cantino D; Biasi F; Chiarpotto E; Salizzoni M; Andorno E; Massano G; Lanfranco G; Rizzetto M; Boveris A; Poli G
    Hepatology; 1996 Nov; 24(5):1053-7. PubMed ID: 8903374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of phenobarbital on bile salt metabolism in cholestasis due to intrahepatic bile duct hypoplasia.
    Stiehl A; Thaler MM; Admirand WH
    Pediatrics; 1973 Jun; 51(6):992-7. PubMed ID: 4710459
    [No Abstract]   [Full Text] [Related]  

  • 16. Using octreotide for refractory ascites after liver transplantation.
    Nutu OA; Manrique Municio A; Marcacuzco Quinto A; Calvo Pulido J; Jiménez Romero C
    Rev Esp Enferm Dig; 2019 Nov; 111(11):882-884. PubMed ID: 31595758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of bile salts and biliary lipids early after liver transplantation differentiate patients with unfavorable graft outcome.
    Tisone G; Angelico M; Baiocchi L; Nistri A; Pisani F; Gandin C; Romagnoli J; Anselmo A; Umberto Casciani C
    Transplant Proc; 1996 Jun; 28(3):1655-6. PubMed ID: 8658824
    [No Abstract]   [Full Text] [Related]  

  • 18. FK 506 improves recovery of bile secretion following orthotopic liver transplantation in man.
    Söderdahl G; Groth CG; Angelin B; Duraj F; Einarsson K; Ericzon BG
    Transplant Proc; 1995 Feb; 27(1):1125. PubMed ID: 7533362
    [No Abstract]   [Full Text] [Related]  

  • 19. Impaired activity of the bile canalicular organic anion transporter (Mrp2/cmoat) is not the main cause of ethinylestradiol-induced cholestasis in the rat.
    Koopen NR; Wolters H; Havinga R; Vonk RJ; Jansen PL; Müller M; Kuipers F
    Hepatology; 1998 Feb; 27(2):537-45. PubMed ID: 9462655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucocele formation of cystic bile duct remnant after orthotopic liver transplantation.
    Liang TB; Zhao ZC; Jia CK; Zheng SS
    Chin Med J (Engl); 2007 Feb; 120(3):254-6. PubMed ID: 17355834
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.